Jama Author Interviews: Covering Research In Medicine, Science, & Clinical Practice. For Physicians, Researchers, & Clinician

Sinopsis

Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.

Episodios

  • Coronavirus QA: Clinical Update With Carlos del Rio, MD

    Coronavirus Q&A: Clinical Update With Carlos del Rio, MD

    17/06/2020 Duración: 34min

    Infectious disease and global health expert Carlos del Rio, MD, of Emory University provides an update on the status of the #COVID19 pandemic in summer 2020, prospects for effective treatment and prevention, communicating the ongoing risk to the public, and more. Recorded June 15, 2020. Related Article: Translating Science on COVID-19 to Improve Clinical Care and Support the Public Health Response

  • Sustainability, Business, and Health

    Sustainability, Business, and Health

    17/06/2020 Duración: 26min

    Interview with Howard K. Koh, MD, author of Sustainability, Business, and Health Related Article(s): Sustainability, Business, and Health

  • Hospice Carve-In—Aligning Benefits With Patient and Family Needs

    Hospice Carve-In—Aligning Benefits With Patient and Family Needs

    15/06/2020 Duración: 22min

    Interview with William H. Shrank, MD, author of Hospice Carve-In—Aligning Benefits With Patient and Family Needs Related Article: Hospice Carve-In—Aligning Benefits With Patient and Family Needs

  • COVID-19 QA: Critical Care Update

    COVID-19 Q&A: Critical Care Update

    10/06/2020 Duración: 50min

    COVID-19 critical care update with Maurizio Cecconi, MD, of Humanitas University in Milan, Italy, and JAMA Associate Editor Derek C. Angus, MD, MPH, of the University of Pittsburgh. Recorded June 8, 2020. Related: Management of COVID-19 Respiratory Distress

  • USPSTF Recommendation: Screening for Unhealthy Drug Use

    USPSTF Recommendation: Screening for Unhealthy Drug Use

    09/06/2020 Duración: 15min

    Interview with Karina W. Davidson, PhD, USPSTF member and coauthor of Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement

  • Can Infections Cause Alzheimer Disease?

    Can Infections Cause Alzheimer Disease?

    08/06/2020 Duración: 21min

    Interview with Anthony L. Komaroff, MD, author of Can Infections Cause Alzheimer Disease?

  • Coronavirus QA: Opening School in the Fall

    Coronavirus Q&A: Opening School in the Fall

    05/06/2020 Duración: 34min

    Joshua M. Sharfstein, MD, and Christopher Morphew, PhD, of Johns Hopkins University discuss options for opening primary, middle, and high schools in fall 2020. Recorded June 3, 2020. Related Article: The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020

  • Coronavirus QA With Anthony Fauci, MD

    Coronavirus Q&A With Anthony Fauci, MD

    04/06/2020 Duración: 26min

    NIAID Director Anthony Fauci, MD, discusses recent developments in the global COVID-19 pandemic with JAMA Editor in Chief Howard Bauchner, MD. Recorded June 2, 2020. Related Article: Anthony Fauci, MD, on COVID-19 Vaccines, Larry Kramer, and Dealing With Criticism

  • Coronavirus Vaccine Development

    Coronavirus Vaccine Development

    03/06/2020 Duración: 36min

    Paul Offit, MD, of the Children's Hospital of Philadelphia, discusses principles and progress to date in COVID-19 vaccine development. Recorded June 1, 2020. Related: Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust

  • Coronavirus QA: Managing the Pandemic

    Coronavirus Q&A: Managing the Pandemic

    01/06/2020 Duración: 31min

    Paul Starr, PhD, Professor of Sociology and Public Affairs at Princeton University, discusses policy options for achieving a new normal in the COVID-19 pandemic. Recorded Thursday, May 28, 2020. Related Article: Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic

  • Potential Implications of Lowering the Medicare Eligibility Age to 60

    Potential Implications of Lowering the Medicare Eligibility Age to 60

    29/05/2020 Duración: 29min

    Interview with Zirui Song, M.D., Ph.D., author of Potential Implications of Lowering the Medicare Eligibility Age to 60

  • Reporting USMLE Step 1 Scores as Pass/Fail: An Opportunity for Medical Education and Training

    Reporting USMLE Step 1 Scores as Pass/Fail: An Opportunity for Medical Education and Training

    26/05/2020 Duración: 34min

    Interview with Humayun J. Chaudhry, DO, author of The USMLE Step 1 Decision: An Opportunity for Medical Education and Training

  • USPSTF Recommendation: Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults

    USPSTF Recommendation: Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults

    26/05/2020 Duración: 14min

    Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of Primary Care–Based Interventions to Prevent Illicit Drug Use in Children, Adolescents, and Young Adults: US Preventive Services Task Force Recommendation Statement

  • The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative

    The NIH Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Initiative

    21/05/2020 Duración: 37min

    US National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, discusses the agency's new initiative to collaborate with other agencies and industry to accelerate development and testing of COVID-19 treatments and vaccines. Recorded May 19, 2020. Related: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times

  • Immunity Passports in the Time of COVID-19

    Immunity Passports in the Time of COVID-19

    13/05/2020 Duración: 40min

    Ezekiel Emanuel, MD, PhD, of the Perelman School of Medicine's Department of Medical Ethics and Health Policy, discusses the use of immunity licensing (immunity passports) as a means to restore public travel, activity, and the economy following the first wave of the COVID-19 pandemic. Recorded May 11, 2020. Related: The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”)

  • When Should Physicians Act on Non–Statistically Significant Results From Clinical Trials?

    When Should Physicians Act on Non–Statistically Significant Results From Clinical Trials?

    08/05/2020 Duración: 29min

    Interview with Paul J. Young, PhD, author of When Should Clinicians Act on Non–Statistically Significant Results From Clinical Trials?

  • Coronavirus QA: Update From the CDC

    Coronavirus Q&A: Update From the CDC

    06/05/2020 Duración: 35min

    Anne Schuchat, MD, Principal Deputy Director of the Centers for Disease Control and Prevention (CDC), discusses evolution of CDC guidance and latest developments in the COVID-19 pandemic. Recorded Friday May 1, 2020.

  • COVID-19 and Health Cares New Normal

    COVID-19 and Health Care's New Normal

    06/05/2020 Duración: 33min

    Don Berwick, MD, MPP, of the Institute for Healthcare Improvement, discusses choices societies and the medical profession can make to improve health care and reduce inequities as we move out of the acute phase of the coronavirus pandemic.

  • Understanding Brain Death

    Understanding Brain Death

    01/05/2020 Duración: 22min

    Interview with Robert D. Truog, MD, MA, author of Understanding Brain Death

  • COVID-19 and US Health Care Spending

    COVID-19 and US Health Care Spending

    29/04/2020 Duración: 32min

    The US spends more on health care as a proportion of its GDP than any other nation. Will the COVID-19 pandemic reduce or accelerate that spending? Sherry Glied, PhD, Dean and Professor of Public Service at New York University, explains. Recorded Monday, April 27, 2020. Read the article The Potential Effects of Coronavirus on National Health Expenditures

página 1 de 30

Informações: